Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel ...

Hims & Hers Health (HIMS, Financials) shares slumped 24.5% on Thursday as Amazon (AMZN, Financials) expanded into hair loss ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Billionaire hedge fund manager Bill Ackman increased his bets by fivefold in Nike ( NKE ), suggesting potential changes to unlock shareholder value.

Health-care companies fell sharply after reports that Donald Trump will pick Robert F. Kennedy Jr. as his nominee for head of Health and Human Services Department.

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

Here are five key things investors need to know to start the trading day: Stocks moved lower Thursday, as the Dow Jones ...

The Board of each Fund announced today the elevation of independent Director Eileen A. Kamerick to Chair of Board, effective . Ms. Kamerick replaces Jane Trust, the former Chair of the Board of the ...

However, just this week analysts from Morgan Stanley and UBS raised their price targets on Nvidia stock to $160 and $185, ...